TNGX CIK: 1819133

Tango Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
492
FY22:
375
FY23:
347
FY24:
266
FY25:
354
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.82
FY22:
61.2
FY23:
56.0
FY24:
50.1
FY25:
44.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
500
FY22:
436
FY23:
403
FY24:
316
FY25:
399

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
40.7
FY22:
55.5
FY23:
45.9
FY24:
38.2
FY25:
21.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
115
FY22:
131
FY23:
104
FY24:
78.8
FY25:
30.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
345
FY22:
249
FY23:
253
FY24:
200
FY25:
346
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
500
FY22:
436
FY23:
403
FY24:
316
FY25:
399

All amounts in millions USD Data source:SEC EDGAR